Fundraising FoxBrixton
7 known investors
Find your way into Brixton
Sign up to see every warm intro you have to Brixton
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Brixton team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Brixton Bio develops Reneurx therapy, a treatment aimed at providing long-lasting pain relief for up to six months from a single administration. The company operates in the biotech and therapeutics space focused on pain control.
Founders & leadership
Investors · 7
How we know: Angel Physicians Fund's portfolio page · Not right? Tell us
How we know: Catalyst Health Ventures's portfolio page · Not right? Tell us
How we know: Excelestar Ventures's portfolio page · Not right? Tell us
How we know: FemHealth Ventures's portfolio page · the VCSheet dataset · Not right? Tell us
Non-dilutive funding · 1 SBIR/STTR award
Federal grants — no equity taken| Agency | Phase | Year | Amount |
|---|---|---|---|
| National Institutes of Health (NIH)National Institutes of Health | Phase ISTTR | 2022 | $252.1K |
Source: SBIR.gov award data (U.S. Small Business Administration). SBIR/STTR awards are competitive federal R&D grants and contracts — non-dilutive capital alongside any venture rounds above.
Frequently asked questions
- What does Brixton do?
- Brixton Bio develops Reneurx therapy, a treatment aimed at providing long-lasting pain relief for up to six months from a single administration. The company operates in the biotech and therapeutics space focused on pain control.
- Who founded Brixton?
- Brixton was founded by Charles Sidoti.
- Who are Brixton's investors?
- Brixton's investors include Angel Physicians Fund, Catalyst Health Ventures, Excelestar Ventures, FemHealth Ventures, Schooner Capital, Sparta Group, SV Health Investors.